Patents-Review.com
ClassID:

117513 ⎘

C12Y401/01028 - CPC Classification

Classification description:

Carbon-carbon lyases (4.1); Carboxy-lyases (4.1.1) Aromatic-L-amino-acid decarboxylase (4.1.1.28), i.e. tryptophane-decarboxylase

Recent Application in this class:
#1
20260117234
2026-04-30

GENE SEQUENCE CONSTRUCT USED FOR TREATMENT OF CENTRAL NERVOUS SYSTEM DISEASES

 #2
20260092179
2026-04-02

GENETICALLY MODIFIED HOST CELLS PRODUCING VIOLACEIN, ANALOGUES, AND DERIVATIVES THEREOF

 #3
20250381299
2025-12-18

GENE THERAPY FOR AADC DEFICIENCY

 #4
20250376706
2025-12-11

RECOMBINANT MICROORGANISMS THAT CATABOLIZE LIGNIN AROMATICS AND METHODS OF USING SAME

 #5
20250195629
2025-06-19

SITE-SPECIFIC BRAIN THERAPEUTICS

 #6
20250171815
2025-05-29

PRODUCTION OF PSYCHEDELIC COMPOUNDS

 #7
20250051750
2025-02-13

AADC/GDNF POLYNUCLEOTIDE, AND USE THEREOF IN TREATING PARKINSON'S DISEASE

 #8
20250041456
2025-02-06

RECOMBINANT AAV VECTORS FOR TREATING NEURODEGENERATIVE DISORDERS

 #9
20240415943
2024-12-19

AADC POLYNUCLEOTIDES FOR THE TREATMENT OF PARKINSON'S DISEASE

 #10
20240316164
2024-09-26

ENHANCED EXPRESSION OF AN AROMATIC AMINO ACID DECARBOXYLASE (AADC) IN THE SUBSTANTIA NIGRA FOR THE TREATMENT OF PARKINSON'S DISEASE

 #11
20240116992
2024-04-11

PROTEIN-BASED MATERIAL FOR BIOCATALYSIS

 #12
20240100186
2024-03-28

GENE THERAPY FOR AADC DEFICIENCY

 #13
20240043884
2024-02-08

RECOMBINANT ESCHERICHIA COLI FOR PRODUCING GLUTARATE, CONSTRUCTION METHOD AND USE THEREOF

 #14
20230357744
2023-11-09

ENGINEERED TRYPTOPHAN DECARBOXYLASES AND USES THEREOF FOR SYNTHESIZING TRYPTAMINE ANALOGS

 #15
20230302158
2023-09-28

ARTIFICIAL EXPRESSION CONSTRUCTS FOR MODULATING GENE EXPRESSION IN STRIATAL NEURONS

 #16
20230263864
2023-08-24

THERAPEUTIC MICROBES

 #17
20230242939
2023-08-03

METHODS AND SYSTEMS FOR PRODUCING AAV PARTICLES

 #18
20230242919
2023-08-03

ENZYMES AND REGULATORY PROTEINS IN TRYPTAMINE METABOLISM

 #19
20230098772
2023-03-30

ADVANCED MICROBIOME THERAPEUTICS ENGINEERED TO PRODUCE SEROTONIN IN VIVO

 #20
20230051548
2023-02-16

Nitrilated psilocybin derivatives and methods of using

 #21
20220204950
2022-06-30

A NEW TYPE OF ENZYME COMPOSITION

 #22
20220090154
2022-03-24

Pterin-dependent biocatalysts and uses thereof

 #23
20210395717
2021-12-23

RECOMBINANT HOST CELL FOR PRODUCING BENZYLISOQUINOLINE ALKALOID (BIA) AND NOVEL METHOD FOR PRODUCING BENZYLISOQUINOLINE ALKALOID (BIA)

 #24
20210338786
2021-11-04

AADC polynucleotides for the treatment of Parkinson's disease

 #25
20210317475
2021-10-14

RECOMBINANT AAV VECTORS USEFUL FOR REDUCING IMMUNITY AGAINST TRANSGENE PRODUCTS

 #26
20210236653
2021-08-05

Gene therapy for AADC deficiency

 #27
20210198691
2021-07-01

Compositions and methods for the treatment of Parkinson's disease

 #28
20210147822
2021-05-20

Engineered decarboxylase polypeptides and their uses in preparing tyramine and dopamine

 #29
20210017524
2021-01-21

Benzylisoquinoline Alkaloid (BIA) Precursor Producing Microbes, and Methods of Making and Using the Same

 #30
20210010028
2021-01-14

INSECT CELL MANUFACTURED PARTIAL SELF-COMPLEMENTARY AAV GENOMES

 #31
20200397919
2020-12-24

GENE SEQUENCE CONSTRUCT USED FOR TREATMENT OF CENTRAL NERVOUS SYSTEM DISEASES

 #32
20200048615
2020-02-13

Inhibition of serotonin expression in gut enteroendocrine cells results in conversion to insulin-positive cells

 #33
20190358306
2019-11-28

AADC polynucleotides for the treatment of Parkinson's disease

 #34
20190343937
2019-11-14

AADC polynucleotides for the treatment of Parkinson's disease

 #35
20190322996
2019-10-24

3-methylcrotonic acid decarboxylase (MDC) variants

 #36
20190282628
2019-09-19

RECOMBINANT BACTERIA ENGINEERED TO TREAT DISEASES AND DISORDERS ASSOCIATED WITH AMINO ACID METABOLISM AND METHODS OF USE THEREOF

 #37
20190060425
2019-02-28

AADC POLYNUCLEOTIDES FOR THE TREATMENT OF PARKINSON'S DISEASE

 #38
20190055567
2019-02-21

Benzylisoquinoline alkaloid (BIA) precursor producing microbes, and methods of making and using the same

 #39
20190054158
2019-02-21

COMPOSITIONS AND METHODS FOR THE TREATMENT OF AADC DEFICIENCY

 #40
20190008933
2019-01-10

AADC POLYNUCLEOTIDES FOR THE TREATMENT OF PARKINSON'S DISEASE

 #41
20190008932
2019-01-10

AADC POLYNUCLEOTIDES FOR THE TREATMENT OF PARKINSON'S DISEASE

 #42
20190008931
2019-01-10

AADC POLYNUCLEOTIDES FOR THE TREATMENT OF PARKINSON'S DISEASE

 #43
20190000991
2019-01-03

Gene therapy for AADC deficiency

 #44
20190000940
2019-01-03

COMPOSITIONS AND METHODS FOR THE TREATMENT OF AADC DEFICIENCY

 #45
20180243249
2018-08-30

METHODS OF TREATING PARKINSON'S DISEASE USING VIRAL VECTORS

 #46
20180163212
2018-06-14

Benzylisoquinoline alkaloid (BIA) precursor producing microbes, and methods of making and using the same

 #47
20180066279
2018-03-08

RECOMBINANT AAV VECTORS USEFUL FOR REDUCING IMMUNITY AGAINST TRANSGENE PRODUCTS

 #48
20170362617
2017-12-21

Pterin-dependent biocatalysts and uses thereof

 #49
20170333538
2017-11-23

AADC polynucleotides for the treatment of parkinson's disease

 #50
20170321217
2017-11-09

Antisense oligonucleotide for splicing adjustment of mutant dopa decarboxylase gene and using method thereof

 #51
20170204375
2017-07-20

Inhibition of serotonin expression in gut enteroendocrine cells results in conversion to insulin-positive cells

 #52
20170166925
2017-06-15

Recombinant AAV vectors useful for reducing immunity against transgene products

 #53
20160256534
2016-09-08

METHODS OF TREATING PARKINSON'S DISEASE USING VIRAL VECTORS

 #54
20160230200
2016-08-11

MICROORGANISMS FOR EFFICIENT PRODUCTION OF MELATONIN AND RELATED COMPOUNDS

 #55
20150284753
2015-10-08

Process for the preparation of an intermediate for an orexin receptor antagonist

 #56
20150024440
2015-01-22

MICROORGANISMS FOR THE PRODUCTION OF MELATONIN

 #57
20100104537
2010-04-29

Methods of treating Parkinson's disease using viral vectors

 #58
20070098807
2007-05-03

Matrices for drug delivery and methods for making and using the same

 #59
20050180955
2005-08-18

Methods of treating parkinson's disease using viral vectors